LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | GR_AOC |
---|---|---|
Hs 578T | PF477736 | 0.7780 |
Hs 578T | PF562271 | 0.3962 |
Hs 578T | PHA-665752 | 0.1158 |
Hs 578T | PHA-793887 | 0.8310 |
Hs 578T | PI103 | 0.7197 |
Hs 578T | PIK-93 | 0.1800 |
Hs 578T | PLX-4720 | -0.0435 |
Hs 578T | QL-X-138 | 0.4643 |
Hs 578T | QL-XII-47 | 0.4994 |
Hs 578T | R406 | 0.2744 |
Hs 578T | Radicicol | 0.4846 |
Hs 578T | Sirolimus | 0.3724 |
Hs 578T | Ruxolitinib | 0.0710 |
Hs 578T | Saracatinib | 0.2511 |
Hs 578T | SB590885 | -0.0425 |
Hs 578T | Selumetinib | 0.5457 |
Hs 578T | Sigma A6730 | 0.1411 |
Hs 578T | Sorafenib | -0.1124 |
Hs 578T | SU11274 | 0.1522 |
Hs 578T | Fedratinib | 0.3610 |
Hs 578T | TGX221 | 0.1622 |
Hs 578T | Torin1 | 0.8745 |
Hs 578T | Torin2 | 0.9986 |
Hs 578T | Tozasertib | 0.9070 |
Hs 578T | Trametinib | 0.8049 |